Cargando…

Evolution of blood lipids and risk factors of dyslipidemia among people living with human immunodeficiency virus who had received first-line antiretroviral regimens for 3 years in Shenzhen

BACKGROUND: Lipid abnormalities are prevalent among people living with human immunodeficiency virus (HIV) (PLWH) and contribute to increasing risk of cardiovascular events. This study aims to investigate the incidence of dyslipidemia and its risk factors in PLWH after receiving different first-line...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sun, Li-Qin, Liu, Jia-Ye, He, Yun, Zhou, Yang, Xu, Liu-Mei, Zhang, Lu-Kun, Zhao, Fang, Liu, Xiao-Ning, Song, Ying, Cao, Ting-Zhi, Tian, Yi-Mei, Rao, Man, Wang, Hui
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams & Wilkins 2020
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10631593/ https://www.ncbi.nlm.nih.gov/pubmed/33273329 http://dx.doi.org/10.1097/CM9.0000000000001245

Ejemplares similares

Serum lipids and associated factors of dyslipidemia in the adult population in Shenzhen
por: Ni, Wen-Qing, et al.
Publicado: (2015)

Adverse events in Chinese human immunodeficiency virus (HIV) patients receiving first line antiretroviral therapy
por: Dai, Lili, et al.
Publicado: (2020)

Role of Proviral HIV-1 DNA Genotyping for People Living with HIV (PLWH) Who Had Low-Level Viremia While Receiving Antiretroviral Therapy
por: Lv, Shiyun, et al.
Publicado: (2023)

Treatment of immune thrombocytopenia with eltrombopag in patients who had and who had not received prior rituximab: post‐hoc analysis of the EXTEND study
por: Meyer, Oliver, et al.
Publicado: (2021)

Trends in Genotypic HIV-1 Antiretroviral Resistance between 2006 and 2012 in South African Patients Receiving First- and Second-Line Antiretroviral Treatment Regimens
por: Van Zyl, Gert U., et al.
Publicado: (2013)

Impact of second-line antiretroviral regimens on lipid profiles in an African setting: the DART trial sub-study
por: Gomo, Zvenyika AR, et al.
Publicado: (2014)

Comparison of self-reported symptoms in COVID-19 patients who had or had not previously received COVID-19 mRNA vaccination
por: Hara, Megumi, et al.
Publicado: (2023)

Risk factors and longitudinal changes of dyslipidemia among Chinese people living with HIV receiving antiretroviral therapy
por: Li, Xiuxia, et al.
Publicado: (2023)

Lipid profiles of people with human immunodeficiency virus with dyslipidemia after switching from efavirenz to dolutegravir
por: Khemla, Supphachoke, et al.
Publicado: (2023)

A Case of Esophageal Candidiasis in an Adolescent Who Had Frequently Received Budesonide Nebulizing Therapy
por: Kang, Hae Ryong, et al.
Publicado: (2013)

Antiretroviral Regimen and Suboptimal Medication Adherence Are Associated With Low-Level Human Immunodeficiency Virus Viremia
por: Konstantopoulos, Christina, et al.
Publicado: (2015)

Comparison of Two Antiretroviral Therapy Regimens in Human Immunodeficiency Virus (HIV−) Infected Pregnant Women
por: Tate, Danielle, et al.
Publicado: (2017)

Incidence and Predictors of First Line Antiretroviral Regimen Modification in Western Kenya
por: Inzaule, Seth, et al.
Publicado: (2014)

The Osteoblastogenesis Potential of Adipose Mesenchymal Stem Cells in Myeloma Patients Who Had Received Intensive Therapy
por: Lin, Hsiu-Hsia, et al.
Publicado: (2014)

Prognostic Impact of Carcinoembryonic Antigen Levels in Rectal Cancer Patients Who Had Received Neoadjuvant Chemoradiotherapy
por: Joo, Jung Il, et al.
Publicado: (2021)

Prevalence of Dyslipidemia Among Antiretroviral-Naive HIV-Infected Individuals in China
por: Shen, Yinzhong, et al.
Publicado: (2015)

Molecular transmission network of pretreatment drug resistance among human immunodeficiency virus-positive individuals and the impact of virological failure on those who received antiretroviral therapy in China
por: Chen, Hongli, et al.
Publicado: (2022)

Differences in Lipid Measurements by Antiretroviral Regimen Exposure in Cohorts from Asia and Australia
por: Achhra, Amit C., et al.
Publicado: (2012)

Central obesity & dyslipidemia in HIV patients on antiretroviral therapy
por: Kumar, Sanjay, et al.
Publicado: (2018)

Characteristics of Older Adults who Receive Assistance with Management of Multidrug Regimens
por: O'Conor, Rachel, et al.
Publicado: (2021)

Lipid-lowering agents for dyslipidemia in patients who were infected with HIV in Taoyuan, Taiwan
por: Cheng, Shu-Hsing, et al.
Publicado: (2014)

Enzootic Angiostrongyliasis in Shenzhen, China
por: Zhang, Ren-Li, et al.
Publicado: (2008)

Response to Booster Doses of Hepatitis B Vaccine among Young Adults Who Had Received Neonatal Vaccination
por: Chan, Paul K. S., et al.
Publicado: (2014)

The Successful Application of a National Peer Advisory Committee for Physicians Who Provide Salvage Regimens to Heavily Antiretroviral-Experienced Patients in Mexican Human Immunodeficiency Virus Clinics
por: Calva, Juan J., et al.
Publicado: (2014)

Prediction of Early Recurrence of Hepatocellular Carcinoma in Patients with Cirrhosis Who Had Received Deceased Donor Liver Transplantation: A Multicenter Study
por: Al-Ameri, Abdulahad Abdulrab Mohammed, et al.
Publicado: (2019)

The Effect of BMI on Blood Lipids and Dyslipidemia in Lactating Women
por: Yu, Lianlong, et al.
Publicado: (2022)

Clinical and paraclinical aspects of HIV infected patients with first-line antiretroviral regimens
por: Bîstrițchi, Ina, et al.
Publicado: (2013)

Assessment of Noninvasive Markers of Steatosis and Liver Fibrosis in Human Immunodeficiency Virus-Monoinfected Patients on Stable Antiretroviral Regimens
por: Busca, C, et al.
Publicado: (2022)

Antiretroviral therapy uptake and predictors of virological failure in patients with HIV receiving first-line and second-line regimens in Johannesburg, South Africa: a retrospective cohort data analysis
por: Gumede, Siphamandla Bonga, et al.
Publicado: (2022)

Mutational Correlates of Virological Failure in Individuals Receiving a WHO-Recommended Tenofovir-Containing First-Line Regimen: An International Collaboration
por: Rhee, Soo-Yon, et al.
Publicado: (2017)

First-line antiretroviral therapy and dyslipidemia in people living with HIV-1 in Cameroon: a cross-sectional study
por: Pefura Yone, Eric Walter, et al.
Publicado: (2011)

Diabetes Dyslipidemia
por: Schofield, Jonathan D., et al.
Publicado: (2016)

Dyslipidemia and fasting glucose impairment among HIV patients three years after the first antiretroviral regimen in a Brazilian AIDS outpatient clinic
por: Pinto Neto, Lauro Ferreira da Silva, et al.
Publicado: (2013)

Successful treatment with vedolizumab in an adolescent with Crohn disease who had developed active pulmonary tuberculosis while receiving infliximab
por: Choi, Sujin, et al.
Publicado: (2021)

Proper adjuvant therapy in patients with borderline resectable and locally advanced pancreatic cancer who had received neoadjuvant FOLFIRINOX
por: Choi, Jin Ho, et al.
Publicado: (2022)

A case of malignant mesothelioma in a young patient with childhood leukaemia who had received total body irradiation
por: Hayat, Redwan, et al.
Publicado: (2023)

The physical activity levels among people living with human immunodeficiency virus/acquired immunodeficiency syndrome receiving high active antiretroviral therapy in Rwanda
por: Frantz, J.M., et al.
Publicado: (2014)

Hepatotoxicity in patients co-infected with HIV and tuberculosis while receiving NNRTI-based antiretroviral regimen and rifampicin
por: Mankhatitham, W, et al.
Publicado: (2010)

Ten-year Time-trend Analysis of Dyslipidemia Among Adults in Wuhan
por: Zhang, Man, et al.
Publicado: (2022)

Desimplification to multi-tablet antiretroviral regimens in human immunodeficiency virus-type 1 infected adults: A cohort study
por: Rossi, Maria C, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_63v22ld2v33jvjtcg9phod5j4t